Search Page

1

Cite

Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales.

Falcone M, Daikos GL, Tiseo G, Bassoulis D, Giordano C, Galfo V, Leonildi A, Tagliaferri E, Barnini S, Sani S, Farcomeni A, Ghiadoni L, Menichetti F. Falcone M, et al. Among authors: barnini s. Clin Infect Dis. 2021 Jun 1;72(11):1871-1878. doi: 10.1093/cid/ciaa586. Clin Infect Dis. 2021. PMID: 32427286

Cite

2

Cite

Clinical Features and Outcomes of Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales: A 3-Year Prospective Study From an Endemic Area.

Falcone M, Giordano C, Leonildi A, Galfo V, Lepore A, Suardi LR, Riccardi N, Barnini S, Tiseo G. Falcone M, et al. Among authors: barnini s. Clin Infect Dis. 2024 May 15;78(5):1111-1119. doi: 10.1093/cid/ciad725. Clin Infect Dis. 2024. PMID: 38036465

Cite

3

Cite

Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.

Falcone M, Tiseo G, Leonildi A, Della Sala L, Vecchione A, Barnini S, Farcomeni A, Menichetti F. Falcone M, et al. Among authors: barnini s. Antimicrob Agents Chemother. 2022 May 17;66(5):e0214221. doi: 10.1128/aac.02142-21. Epub 2022 Mar 21. Antimicrob Agents Chemother. 2022. PMID: 35311522 Free PMC article.

Cite

4

Cite

Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections.

Shields RK, Dorazio AJ, Tiseo G, Squires KM, Leonildi A, Giordano C, Kline EG, Barnini S, Iovleva A, Griffith MP, Van Tyne D, Doi Y, Falcone M. Shields RK, et al. Among authors: barnini s. JAC Antimicrob Resist. 2024 Sep 9;6(5):dlae146. doi: 10.1093/jacamr/dlae146. eCollection 2024 Oct. JAC Antimicrob Resist. 2024. PMID: 39253335 Free PMC article.

Cite

5

Cite

Regional sepsis care in Catalonia: comparative insights from a secondary analysis of the European Sepsis Care Survey.

Ceccato A, Scheer CS, Ferrer R, Martinez ML, Cisteró B, Yébenes JC, Trenado J, Lorencio C, Linder A, Filipescu D, Idelevich EA, Giamarellos-Bourboulis EJ, Artigas A; European Sepsis Care Study Group. Ceccato A, et al. Crit Care. 2025 Aug 19;29(1):367. doi: 10.1186/s13054-025-05507-3. Crit Care. 2025. PMID: 40830495 Free PMC article. No abstract available.

Cite

6

Cite

Recent advances in the microbiological diagnosis of bloodstream infections.

Florio W, Morici P, Ghelardi E, Barnini S, Lupetti A. Florio W, et al. Among authors: barnini s. Crit Rev Microbiol. 2018 May;44(3):351-370. doi: 10.1080/1040841X.2017.1407745. Epub 2017 Nov 29. Crit Rev Microbiol. 2018. PMID: 29185372 Review.

Cite

7

Cite

Real-world experience with meropenem/vaborbactam for the treatment of infections caused by ESBL-producing Enterobacterales and carbapenem-resistant Klebsiella pneumoniae.

Tiseo G, Galfo V, Riccardi N, Suardi LR, Pogliaghi M, Giordano C, Leonildi A, Barnini S, Falcone M. Tiseo G, et al. Among authors: barnini s. Eur J Clin Microbiol Infect Dis. 2024 Feb 20. doi: 10.1007/s10096-024-04758-2. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38376634

Cite

8

Cite

Pharyngeal and cutaneous diphtheria: a tail of a refugee.

Galfo V, Riccardi N, Leonildi A, Falcone M, Barnini S. Galfo V, et al. Among authors: barnini s. Infection. 2023 Oct;51(5):1599-1600. doi: 10.1007/s15010-023-01990-4. Epub 2023 Jan 31. Infection. 2023. PMID: 36719633 No abstract available.

Cite

9

Cite

Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa.

Gill CM, Nicolau DP; ERACE-PA Global Study Group. Gill CM, et al. J Antimicrob Chemother. 2022 Dec 23;78(1):252-256. doi: 10.1093/jac/dkac385. J Antimicrob Chemother. 2022. PMID: 36411249 Free PMC article.

Cite

10

Cite

Meropenem/vaborbactam plus aztreonam for the treatment of New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae infections.

Tiseo G, Suardi LR, Leonildi A, Giordano C, Barnini S, Falcone M. Tiseo G, et al. Among authors: barnini s. J Antimicrob Chemother. 2023 Sep 5;78(9):2377-2379. doi: 10.1093/jac/dkad206. J Antimicrob Chemother. 2023. PMID: 37392133 No abstract available.

Cite